Definitive Contract 75F40121C00154
Award Date
9/17/21
Potential Completion Date
9/30/24
Potential Value
$504K
Federal Agency
Food and Drug Administration
Awardee
University Of Tennessee
Ultimate Awardee
Board Of Regents Tennessee
NAICS Category
611310 - Colleges, Universities, and Professional Schools
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Available for Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Jefferson, AR 72079, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The University of Tennessee, doing business as Finance and Operation, was awarded a $623,991 Cost No Fee contract from the Food and Drug Administration (FDA) to conduct a longitudinal quantitative evaluation of the clinical, immunological, and virological characteristics of COVID-19 in mucosal, blood, and fecal specimens from adults, children, and exposed household members. This contract is not set aside. The University of Tennessee is a major public research institution and land-grant...
This is a $24,919 firm-fixed price purchase order contract awarded by the U.S. Food and Drug Administration (FDA) to the University of Tennessee to develop standard operating procedures (SOPs) to ensure viral inactivation in various maternal and fetal tissue samples and blood prior to shipment to the FDA's National Center for Toxicological Research (NCTR). The contract has no set-aside designation and was awarded on July 8, 2021, with a completion date of July 7, 2022. The University of...
This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to the University of Tennessee, operating as the Univ Tennessee System Office. The contract, valued at $9,498,336.00, is for biomedical research and exploration activities. No set-aside designation was used for this definitive contract, which has a cost-no-fee pricing type. The University of Tennessee has extensive experience conducting scientific research and providing analytical services...
The Department of Veterans Affairs awarded a $297,460.26 firm-fixed-price definitive contract to the University of Tennessee Health Science Center for animal maintenance and veterinary services. The contract has an ultimate completion date of August 31, 2021. The University of Tennessee is a major public research institution and land-grant university that receives substantial federal funding for research and development activities, including medical education, biomedical sciences, and infectious...
The University of Tennessee, Knoxville is providing research services as the prime contractor on a $266,332 cost-no-fee contract from the Department of Homeland Security Science and Technology Directorate. The contract is for the period of September 30, 2015 through July 31, 2019 to support the development of a rapid, low-cost, field-deployable diagnostic device for viral infectious diseases in animals, as described in the original solicitation. No set-aside designation was specified for this...
This is a definitive contract awarded by the Department of Health and Human Services National Institutes of Health to the University of Tennessee, a public land grant university, on September 15, 1999. The contract does not have a set-aside designation and has a potential value of $4,003,082.00. The University of Tennessee has substantial experience as a prime contractor and subcontractor, providing analytical and consulting services to the Department of Defense as well as conducting research...
This is a Firm Fixed Price federal contract award to the University of Liverpool, a leading UK research institution, for $9,412,272.00 to characterize severe coronavirus infections. The contract was awarded by the U.S. Food and Drug Administration (FDA), a civilian agency, on September 10, 2020, with a completion date of September 14, 2025. The contract does not have a set-aside designation. Based on the University of Liverpool's expertise in areas such as infectious diseases, immunology, and...
This is a $3,956,154 cost-no-fee definitive contract awarded by the Food and Drug Administration (FDA) to The Leland Stanford Junior University (Stanford University) on September 30, 2020. The contract is for pathology and pathogenesis research on coronavirus infections in animal models, with a performance period through September 30, 2025. The contract was issued under a Broad Agency Announcement (BAA) from the FDA that solicits advanced research and development proposals to support...
This federal contract award was issued by the Department of Veterans Affairs (VA) to the University of Tennessee for research and development services related to molecular resources for the VA Medical Center in Memphis, Tennessee. The contract has a ceiling value of $20,750 and was awarded on a firm-fixed price basis, with a completion date of September 30, 2008. No set-aside designation was used for this contract. The University of Tennessee, a major public research institution and land-grant...
The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $2.5 million delivery order to Utah State University, doing business as USU, to establish small animal models for screening medical countermeasures against SARS-CoV-2, the virus that causes COVID-19. This delivery order was issued against NIAID's Preclinical Models of Infectious Diseases master IDIQ contract, valued between $2.5 billion to $5 billion over its 2017-2024 period of performance, which...